Table 1.
Demographic and clinical characteristics of subjects in the bipolar group
Patient no. | Gender | Age | Scores
|
Daily dosages prescribed (mg)
|
|||||
---|---|---|---|---|---|---|---|---|---|
MADRS | YMRS | GAS | DVPX | Li | LTG | Other | |||
1 | F | 38 | 10 | 9 | 70 | 1250 | 1200 | 0 | |
2 | M | 52 | 10 | 3 | 70 | 500 | 450 | 0 | |
3 | F | 50 | 10 | 14 | 70 | 0 | 675 | 50 | |
4 | M | 46 | 9 | 1 | 61 | 0 | 0 | 300 | Olanzapine 10 |
5 | F | 55 | 6 | 2 | 91 | 0 | 0 | 100 | Clozapine 200 |
6 | F | 35 | 4 | 15 | 75 | 0 | 0 | 300 | Aripiprazole 15 |
7 | F | 62 | 2 | 2 | 90 | 0 | 300 | 100 | Venlafaxine 75 |
8 | M | 64 | 5 | 3 | 85 | 500 | 0 | 50 | Paroxetine 40 |
9 | M | 43 | 6 | 3 | 90 | 250 | 450 | 25 | |
10 | M | 39 | 0 | 5 | 90 | 500 | 600 | 0 | |
11 | F | 34 | 5 | 6 | 75 | 0 | 0 | 200 | Ziprasidone 80 |
12 | F | 36 | 0 | 0 | 85 | 1250 | 0 | 0 | |
13 | M | 36 | 2 | 5 | 85 | 250 | 450 | 0 | Bupropion 150 |
14 | M | 53 | 0 | 1 | 90 | 0 | 600 | 0 | Fluoxetine 20 |
15 | F | 47 | 4 | 1 | 90 | 0 | 900 | 150 | |
16 | M | 23 | 0 | 0 | 85 | 1000 | 0 | 0 | |
17 | M | 23 | 4 | 8 | 85 | 1750 | 1200 | 0 | |
18 | F | 30 | 5 | 2 | 81 | 0 | 0 | 0 | Bupropion 300 |
19 | F | 30 | 0 | 0 | 91 | 0 | 900 | 300 | Sertraline 200 |
20 | F | 51 | 25 | 3 | 51 | 250 | 300 | 100 | |
21 | M | 32 | 23 | 6 | 51 | 1500 | 2250 | 0 | |
22 | F | 45 | 21 | 0 | 55 | 0 | 0 | 200 | Quetiapine 50 |
23 | F | 38 | 19 | 0 | 65 | 0 | 450 | 200 | Aripiprazole 10 |
24 | M | 46 | 16 | 5 | 65 | 250 | 450 | 0 | |
25 | F | 40 | 18 | 32 | 55 | 250 | 675 | 100 | |
26 | F | 47 | 23 | 0 | 60 | 0 | 900 | 0 | Quetiapine 150 |
27 | M | 42 | 15 | 7 | 61 | 2500 | 1500 | 200 | |
28 | F | 43 | 12 | 13 | 71 | 0 | 900 | 200 | Bupropion 300 |
29 | F | 19 | 18 | 10 | 65 | 1500 | 450 | 0 |
F, Female; M, male; MADRS, Montgomery–Asberg Depression Rating Scale; YMRS, Young Mania Rating Scale; GAS, Global Assessment Scale; DVPX, divalproex sodium; Li, lithium carbonate; LTG, lamotorigine.